BioMarin Pharmaceuticals
BMRN
BMRN
411 hedge funds and large institutions have $16.3B invested in BioMarin Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 158 increasing their positions, 148 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
4% less funds holding
Funds holding: 426 → 411 (-15)
17% less first-time investments, than exits
New positions opened: 40 | Existing positions closed: 48
36% less funds holding in top 10
Funds holding in top 10: 14 → 9 (-5)
Holders
411
Holding in Top 10
9
Calls
$97.7M
Puts
$79.3M
Top Buyers
| 1 | +$182M | |
| 2 | +$130M | |
| 3 | +$116M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$75.7M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$75M |
Top Sellers
| 1 | -$119M | |
| 2 | -$86.4M | |
| 3 | -$82M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$61.1M |
| 5 |
YCMGA
York Capital Management Global Advisors
New York
|
-$54.6M |